Cisplatin/Irinotecan With Concurrent Radiation for Inoperable NSCLC

NCT02275806 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped PI decided to terminate study

Conditions

Lung Neoplasms, Non-Small Cell Lung Cancer

Interventions

DRUG: Irinotecan
DRUG: Cisplatin

Sponsor

Leo W. Jenkins Cancer Center